Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19916,805,1.14 [1.03-1.28],0.0157315522715854
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19301,236,1.36 [1.12-1.65],0.0019969620141308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22078,141,1.29 [1.02-1.65],0.0373238557504129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14887,802,1.43 [1.28-1.60],2.2500111203548591e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22037,100,1.29 [0.97-1.72],0.0825552656040829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20007,89,1.45 [1.08-1.96],0.0131981177611603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23073,99,1.30 [0.98-1.74],0.0728367309911465
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23083,67,1.24 [0.87-1.77],0.2324924084246076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19588,52,1.84 [1.31-2.60],0.000506807662196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22108,117,1.40 [1.08-1.81],0.0109501726563212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22074,83,1.42 [1.05-1.93],0.0233324740075269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23159,59,1.08 [0.73-1.61],0.7035388960625457
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23183,60,1.04 [0.70-1.56],0.8356577276874647
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23176,53,1.07 [0.70-1.64],0.7413530756217
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,22849,41,1.55 [1.04-2.32],0.0319436531598201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21926,380,1.15 [0.98-1.35],0.0767373188865836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21695,149,1.18 [0.93-1.51],0.1721930792973333
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21804,258,1.14 [0.94-1.37],0.1872155622251862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18116,77,1.07 [0.74-1.53],0.7214199486698962
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18087,48,0.97 [0.61-1.54],0.8843157425628805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18302,263,1.15 [0.95-1.40],0.1567390717530385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18309,270,1.17 [0.96-1.41],0.1148971327053383
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18267,228,0.92 [0.74-1.14],0.4370243190018346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18092,53,1.10 [0.72-1.68],0.6499764869266917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20588,540,1.32 [1.16-1.50],2.081506536864012e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21703,364,1.09 [0.93-1.29],0.2808838416352542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22594,126,1.04 [0.79-1.37],0.7882635779672102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23219,126,1.32 [1.02-1.70],0.0329392009210002
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,22890,73,0.78 [0.53-1.15],0.2099944003353875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23237,66,1.07 [0.73-1.57],0.7401487991596409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Stomach,23281,48,0.89 [0.55-1.42],0.6192051967786534
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,22967,313,0.89 [0.74-1.07],0.2208988814277577
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23249,107,0.72 [0.52-0.99],0.0463597874299647
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23254,72,0.73 [0.49-1.08],0.1160152887578909
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23204,34,0.67 [0.37-1.20],0.180543474044037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",23207,34,0.67 [0.37-1.20],0.1806257259091424
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,23136,127,1.07 [0.81-1.41],0.6235022274000139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23262,53,1.09 [0.71-1.66],0.6985659784489855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,23167,132,1.03 [0.78-1.35],0.8475679882900665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22108,116,1.38 [1.06-1.80],0.0173802422615722
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21758,253,1.38 [1.15-1.65],0.0003989569280776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21758,253,1.38 [1.15-1.65],0.0003989569280776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19564,503,1.21 [1.05-1.39],0.0071813403798776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22766,38,nan [nan-nan],
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23025,58,0.95 [0.63-1.44],0.8171063537728602
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18237,1421,1.21 [1.11-1.32],2.540009576368812e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22569,177,1.10 [0.87-1.38],0.433162426278867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20550,147,1.45 [1.15-1.83],0.0016840338595429
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21938,162,1.31 [1.05-1.64],0.0186963214685424
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20535,132,1.36 [1.06-1.75],0.0165595463235875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21085,682,1.58 [1.40-1.77],1.2418346419133208e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21059,656,1.55 [1.37-1.74],4.600180547683412e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21560,169,0.87 [0.65-1.17],0.3584231068764829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21560,168,0.86 [0.64-1.15],0.3142758442009554
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18084,1268,1.20 [1.09-1.31],0.0001453936041679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16995,179,1.37 [1.10-1.71],0.0053439736262048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,17984,1168,1.19 [1.08-1.31],0.0004986247392789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16864,48,1.16 [0.75-1.80],0.511481226821813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16915,99,1.40 [1.05-1.87],0.0239583825463261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,19743,669,1.25 [1.11-1.40],0.0002342884354896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19402,328,1.16 [0.98-1.37],0.0841071980579944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22721,256,1.05 [0.87-1.27],0.6243206685932594
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22812,197,1.23 [1.00-1.50],0.0473856848853049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21216,76,0.93 [0.65-1.33],0.706824586622503
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23136,76,0.89 [0.62-1.27],0.5073152201879825
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19150,76,0.94 [0.66-1.33],0.7117793078763799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Alcohol dependence,21253,113,1.32 [1.02-1.72],0.0367903220079943
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,21254,79,1.63 [1.20-2.21],0.0017482990497085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19139,65,1.57 [1.15-2.16],0.0050465221243044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19336,262,1.33 [1.12-1.59],0.001132328647713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression,22113,224,1.32 [1.10-1.60],0.003443379461636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression or dysthymia,19055,191,1.38 [1.13-1.68],0.0015560000976762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19178,104,1.28 [0.97-1.70],0.0829505392998116
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Other anxiety disorders,22299,56,1.25 [0.85-1.84],0.2607905363884168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,19702,1293,1.21 [1.11-1.32],2.24846658788052e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17730,80,1.17 [0.83-1.64],0.3713581630164987
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23184,57,1.19 [0.81-1.76],0.3695388546883463
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21962,533,1.22 [1.07-1.39],0.0031938502030065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,21591,162,0.71 [0.54-0.92],0.0108751845943033
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,21462,33,1.30 [0.78-2.16],0.307859694660677
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23125,27,1.44 [0.85-2.46],0.1790854702815949
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22340,97,1.42 [1.07-1.89],0.0148185981485017
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,21664,235,1.53 [1.28-1.84],4.210340243162182e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,22554,184,1.52 [1.24-1.87],6.278352562741495e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22346,467,1.21 [1.05-1.39],0.0087441808924261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21996,117,1.20 [0.91-1.58],0.1968919582948668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22101,222,1.18 [0.97-1.45],0.1053420472586204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22946,86,1.21 [0.88-1.66],0.2337257053029411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,22915,55,1.33 [0.91-1.95],0.1410661539380755
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,22793,116,1.37 [1.06-1.78],0.0163608834234149
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22703,299,1.10 [0.92-1.32],0.2898832097733081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22576,172,1.11 [0.88-1.40],0.3966897130704353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22479,75,0.85 [0.58-1.24],0.3894947952472113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22506,102,1.03 [0.75-1.40],0.873451932169303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22453,49,1.45 [0.97-2.15],0.0689616649349194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20341,137,1.03 [0.79-1.35],0.8239076674811644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20584,380,1.17 [1.00-1.37],0.0529393653722548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22329,243,1.28 [1.06-1.55],0.0114841326970487
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22880,70,1.81 [1.33-2.46],0.00015045074546
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2545,70,1.59 [1.12-2.25],0.0093073221951394
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20405,70,1.91 [1.41-2.58],3.275697405343926e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22633,97,1.32 [0.99-1.77],0.0623601391739904
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22587,51,1.19 [0.78-1.81],0.4193889106366287
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22747,75,0.87 [0.59-1.26],0.4510527569178147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22770,92,1.01 [0.73-1.41],0.9379337354786468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23188,129,1.14 [0.87-1.48],0.3399152369185967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22347,97,1.14 [0.84-1.55],0.3930865462949019
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15714,3695,1.18 [1.11-1.26],6.168687194361607e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22599,61,0.92 [0.61-1.39],0.6903672519453183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16578,2415,1.25 [1.16-1.34],7.044530543072097e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,16624,2461,1.26 [1.17-1.36],4.5743971269364503e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14269,106,1.71 [1.31-2.22],7.096402593982575e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20608,1640,1.25 [1.15-1.35],9.102488426211016e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,19889,921,1.24 [1.12-1.37],5.653367096516921e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21874,332,1.33 [1.13-1.56],0.0004684455581854
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22262,720,1.33 [1.19-1.49],4.268204894484085e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23086,160,1.25 [0.99-1.58],0.0568991505487252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19459,491,1.37 [1.20-1.56],3.2529519184242342e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20343,1399,1.27 [1.16-1.38],8.512113926059564e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22425,120,1.37 [1.05-1.78],0.0194158335668032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22535,238,1.28 [1.05-1.54],0.012246178182494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22388,83,0.95 [0.67-1.35],0.780569324481615
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22390,85,0.95 [0.67-1.35],0.7747202290662742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14242,79,1.05 [0.73-1.50],0.8037307752103906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18218,77,0.95 [0.66-1.36],0.7653608316499613
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,18308,167,1.22 [0.97-1.54],0.0968181560627715
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11510,134,1.24 [0.95-1.62],0.1172379592396143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11970,594,1.17 [1.01-1.34],0.0324889153580395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,18227,86,1.01 [0.72-1.41],0.9752722441762824
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18268,127,0.96 [0.72-1.28],0.7828447092967095
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22013,310,1.31 [1.11-1.55],0.0016518786964741
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22285,184,1.36 [1.11-1.68],0.0037259125559221
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22307,167,1.44 [1.16-1.79],0.0008327959707206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22391,148,1.40 [1.11-1.77],0.0039496601051081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21907,84,1.00 [0.71-1.41],0.990874331684744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21968,145,1.32 [1.04-1.67],0.0223404502536728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21977,148,1.26 [0.99-1.61],0.058191490916836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21960,131,1.32 [1.02-1.69],0.031702763372015
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23054,123,1.32 [1.02-1.71],0.0329416778523603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,22164,335,0.94 [0.79-1.12],0.4756202001936127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,22043,80,1.33 [0.97-1.83],0.0804440436050127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18150,1977,1.17 [1.09-1.26],2.0795748241054063e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23119,85,1.27 [0.93-1.74],0.1334041943645613
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21202,241,1.20 [0.99-1.46],0.0639862789832215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21167,206,1.13 [0.91-1.40],0.2542502984087862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22320,272,1.38 [1.16-1.64],0.0002917908642718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22317,269,1.38 [1.16-1.64],0.0003459039055616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22449,650,1.04 [0.92-1.18],0.5273908217707923
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,21869,70,0.84 [0.57-1.24],0.3770671054268724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,21963,164,1.05 [0.82-1.34],0.7057795348665766
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22228,429,1.06 [0.91-1.23],0.476127526007815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,22027,228,1.03 [0.84-1.27],0.7610209519863567
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10096,62,1.43 [0.99-2.05],0.0555879704958975
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20810,838,1.21 [1.09-1.35],0.0004033713489152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,21992,191,1.30 [1.06-1.61],0.0127583287648835
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22025,224,1.24 [1.02-1.51],0.0342547860570678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22025,224,1.24 [1.02-1.51],0.0342547860570678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21902,652,1.21 [1.07-1.36],0.0020209573050756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Asthma,15827,652,1.28 [1.14-1.45],4.882945283461492e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15496,652,1.30 [1.15-1.46],2.570529187336263e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15817,642,1.30 [1.15-1.46],2.911486142639948e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22869,100,1.18 [0.87-1.59],0.2812024574179937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,22141,78,1.08 [0.76-1.54],0.6568274274913581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22944,78,1.08 [0.76-1.54],0.6523782392696911
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22134,71,1.17 [0.82-1.67],0.3915493724423754
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,21005,134,1.11 [0.85-1.45],0.4313333545278828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,21155,284,1.07 [0.89-1.28],0.4986639994510271
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21942,126,1.22 [0.94-1.58],0.1438027259810299
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15488,5479,1.10 [1.05-1.17],0.000400063555544
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22802,358,0.99 [0.84-1.17],0.929139618401158
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23253,77,1.29 [0.93-1.79],0.1313760174587553
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,23256,74,1.29 [0.92-1.80],0.141501676587705
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,22553,109,1.28 [0.98-1.69],0.074376595671094
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22522,78,0.77 [0.53-1.12],0.1770163959347421
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23244,86,1.24 [0.90-1.70],0.187386072825705
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22521,77,0.95 [0.66-1.36],0.7661291404487821
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22292,77,1.17 [0.84-1.64],0.3553249989947841
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23186,55,0.99 [0.65-1.50],0.9494952425092992
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17839,315,1.27 [1.08-1.50],0.0046487871801956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19480,1956,1.11 [1.03-1.19],0.0073244532101788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,17902,378,1.09 [0.93-1.28],0.2721796555371926
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18151,627,1.10 [0.97-1.25],0.1326420811758852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17596,72,1.01 [0.70-1.46],0.9566273671676252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17798,274,1.05 [0.87-1.27],0.6018880368216746
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17598,74,0.97 [0.67-1.40],0.8523285762977699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,17678,154,1.33 [1.05-1.68],0.0174839107651049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,17692,168,1.24 [0.99-1.55],0.061529833552119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23095,116,1.24 [0.95-1.63],0.1111161866012748
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,17632,108,0.95 [0.69-1.29],0.7248322329221666
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18289,765,1.09 [0.97-1.22],0.1303938904506403
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,23130,102,1.03 [0.75-1.40],0.8710340086201327
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,17811,287,1.14 [0.95-1.37],0.1485766214195869
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17679,155,0.93 [0.72-1.21],0.6016747449092016
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23089,164,1.07 [0.84-1.36],0.5717688354809134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,23110,82,0.94 [0.66-1.34],0.7384641838383166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,19828,2007,1.03 [0.96-1.11],0.3910107389552771
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,18921,1100,0.99 [0.90-1.10],0.9057583095294062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,18005,184,0.95 [0.75-1.21],0.6781661209631306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,17914,93,1.22 [0.89-1.66],0.2107537339142198
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18571,750,1.12 [1.00-1.25],0.0596599398737211
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22426,585,1.19 [1.05-1.35],0.0063022457194659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,17974,1775,1.09 [1.00-1.18],0.039658605317202
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22950,54,1.46 [1.01-2.10],0.0422073405550057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23210,70,1.34 [0.96-1.87],0.0844403499829182
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,21911,70,1.35 [0.97-1.88],0.0776202429544128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21896,55,1.32 [0.90-1.92],0.1541334361491622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23154,139,1.09 [0.84-1.41],0.5260676023262494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,21980,139,1.10 [0.85-1.43],0.4738774929016404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21966,125,1.17 [0.90-1.53],0.2489084582944702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22280,439,1.19 [1.03-1.37],0.0193546641430261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22277,436,1.19 [1.03-1.38],0.0175672385851133
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16287,88,0.97 [0.69-1.36],0.8510428232512246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal stricture,22832,88,0.95 [0.68-1.34],0.7712761040085419
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16261,62,1.13 [0.76-1.67],0.5527690754592993
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16728,529,1.10 [0.95-1.26],0.1988788284484315
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16284,85,0.96 [0.68-1.36],0.8378316058880843
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16377,178,1.25 [1.00-1.56],0.0472744254711482
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,21739,162,1.23 [0.98-1.55],0.0786948143434582
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22910,47,1.32 [0.88-2.00],0.1794649226979781
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16356,157,1.10 [0.86-1.42],0.4341038586049089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16293,94,1.31 [0.98-1.77],0.0706829701190233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17047,848,1.07 [0.96-1.20],0.203588275164576
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,16507,308,1.14 [0.96-1.36],0.1433275715326182
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22900,37,1.03 [0.69-1.55],0.8790547436567385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,22457,141,1.10 [0.85-1.41],0.483960374091101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,22399,83,1.01 [0.71-1.42],0.97409653238644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22136,359,1.28 [1.10-1.49],0.0017505009562868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,22039,262,1.24 [1.03-1.48],0.0234382645390838
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,21843,66,1.38 [0.97-1.94],0.0701237412860897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21808,31,nan [nan-nan],
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,21847,70,1.26 [0.89-1.78],0.1838751484157571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23088,70,1.25 [0.89-1.77],0.2037065472724062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21933,310,1.22 [1.03-1.44],0.0225892790662152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21661,38,1.28 [0.80-2.03],0.3035485268885536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,21651,28,1.25 [0.73-2.16],0.4150543990413738
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21680,57,1.27 [0.86-1.87],0.2258188657694528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21844,221,1.18 [0.96-1.44],0.1116954812633797
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,21840,217,1.18 [0.96-1.45],0.1071533541066227
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20198,1452,1.05 [0.97-1.15],0.2245344091235509
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22834,89,1.06 [0.77-1.48],0.7077260390851368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22899,440,0.98 [0.85-1.14],0.837403760580969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21688,442,1.11 [0.96-1.29],0.1521911328344477
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22308,460,1.08 [0.93-1.25],0.2969985093228167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21954,106,1.13 [0.84-1.50],0.4193939674511318
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22145,297,1.09 [0.91-1.31],0.3231154121504632
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23011,89,1.09 [0.78-1.51],0.6146594122344884
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22996,74,1.22 [0.86-1.72],0.2639173146297874
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22977,55,1.32 [0.90-1.94],0.151405373957626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22970,56,nan [nan-nan],
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22968,54,nan [nan-nan],
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22515,56,1.13 [0.75-1.69],0.5632066083088257
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22816,357,0.95 [0.81-1.13],0.5824805955054513
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21330,84,1.14 [0.82-1.59],0.4449656283661081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21288,42,0.89 [0.54-1.47],0.655113514377055
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21283,37,0.83 [0.48-1.41],0.486684164244762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21419,173,1.09 [0.86-1.38],0.4592175379969024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21397,151,1.02 [0.79-1.32],0.8792530427711823
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17165,3473,1.08 [1.01-1.14],0.0197283699673774
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18615,2041,1.08 [1.01-1.17],0.0358946326984625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21081,1056,1.04 [0.94-1.15],0.4474667639506495
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16662,88,1.53 [1.14-2.05],0.004278961241894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16977,403,1.22 [1.05-1.42],0.0111838950900842
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23016,85,1.48 [1.10-1.98],0.009192694637298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23021,75,1.56 [1.15-2.11],0.0042879705931925
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17618,1044,1.12 [1.01-1.24],0.0318172733051434
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20008,1044,1.10 [1.00-1.22],0.0532563351494244
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16701,127,1.11 [0.84-1.46],0.4678617394890606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22337,123,1.06 [0.80-1.40],0.6937138414131028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16736,162,1.09 [0.85-1.40],0.4770502393240071
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16630,56,1.28 [0.86-1.90],0.2248727506471308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16829,255,1.11 [0.91-1.35],0.3136570833144831
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23158,122,1.01 [0.76-1.35],0.9474497132654734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17132,558,1.06 [0.93-1.22],0.3837654013845542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16870,296,1.12 [0.93-1.35],0.2190025112535676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17697,1123,1.00 [0.91-1.11],0.9624812477958584
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16595,21,1.12 [0.57-2.19],0.7468801372775384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16619,45,1.35 [0.87-2.08],0.178770031736745
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16602,28,0.91 [0.49-1.69],0.7674027186195694
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16589,15,1.08 [0.47-2.46],0.8523642726512185
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17154,580,0.93 [0.81-1.07],0.326730213529674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17081,507,0.95 [0.82-1.10],0.4679365528194115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18792,254,1.09 [0.89-1.32],0.406334202852832
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22998,33,1.11 [0.66-1.88],0.6848908919171848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22982,17,0.77 [0.35-1.69],0.510076740029631
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20328,42,0.63 [0.37-1.06],0.0833703572760862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20563,277,1.03 [0.85-1.24],0.7637504222014194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21096,810,1.12 [1.00-1.25],0.0458953880932579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20444,158,1.20 [0.94-1.52],0.1372407518704704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20374,88,0.80 [0.56-1.14],0.2211306947649554
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20916,630,1.17 [1.03-1.32],0.0134772806875207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20334,48,1.20 [0.78-1.83],0.4013212150621374
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20503,217,1.26 [1.03-1.53],0.0229582699134472
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20380,94,1.27 [0.94-1.71],0.1209531246612974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20350,64,0.90 [0.60-1.35],0.6117203237410347
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20401,115,1.11 [0.84-1.48],0.4616293723428456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20336,50,1.15 [0.75-1.76],0.5239695190855774
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20544,258,1.29 [1.08-1.55],0.0050039030950545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20259,234,0.94 [0.76-1.16],0.5864167255351027
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20089,64,1.01 [0.68-1.50],0.9577796849395472
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20086,61,0.92 [0.61-1.39],0.6903344196158983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20085,60,1.01 [0.68-1.52],0.9439874127473608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20084,59,1.59 [1.14-2.23],0.0066802634430585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20195,170,0.88 [0.68-1.13],0.3097610598031838
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20184,159,0.87 [0.67-1.13],0.2893353054877231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20270,245,1.14 [0.94-1.39],0.1879422975094544
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20074,49,1.16 [0.76-1.78],0.4891211946631313
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20112,87,1.25 [0.91-1.71],0.1732993391045375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20136,111,0.99 [0.73-1.34],0.9531000290063404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20066,41,0.90 [0.55-1.49],0.6904598169707891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20365,340,1.09 [0.92-1.29],0.3132864647404738
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20160,135,1.09 [0.83-1.42],0.541036490082131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20210,185,1.05 [0.84-1.33],0.6471707776989806
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22267,102,0.84 [0.61-1.17],0.3051042996535704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22453,288,1.09 [0.91-1.31],0.3332381126847255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22220,55,1.21 [0.82-1.79],0.345544888549355
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22216,51,1.05 [0.68-1.63],0.8296512955915036
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22254,89,1.24 [0.91-1.69],0.1822960671258037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17844,2333,1.21 [1.13-1.30],8.323700513171076e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20049,1262,1.10 [1.01-1.21],0.0345361660933117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20524,298,1.55 [1.32-1.82],5.482628087897551e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20316,90,1.08 [0.78-1.49],0.6568771764142863
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20557,73,1.66 [1.24-2.24],0.0007244250006462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20573,89,1.91 [1.48-2.45],5.375284537694524e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20574,90,1.68 [1.28-2.20],0.0001832844209507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22786,352,1.19 [1.01-1.40],0.033871901282763
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22753,77,1.53 [1.13-2.08],0.0059406415144769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22679,245,1.08 [0.88-1.32],0.4567899210325652
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22570,136,1.33 [1.04-1.70],0.023634847173206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21108,820,1.12 [1.01-1.26],0.036245557349029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,20348,60,0.92 [0.60-1.40],0.6937664398631846
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20361,73,1.61 [1.19-2.19],0.0020316921279764
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20661,373,1.13 [0.97-1.33],0.1227761617506311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20429,141,1.34 [1.05-1.71],0.0196027807711722
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20651,363,1.13 [0.96-1.33],0.1478112120066139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19348,561,1.12 [0.98-1.29],0.0928399192285207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18891,104,1.01 [0.74-1.38],0.9421336949945468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydrocele,18883,96,1.14 [0.84-1.56],0.397981416759966
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18947,160,1.30 [1.03-1.63],0.0270124851546777
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18945,158,1.16 [0.91-1.48],0.2286913649070642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19001,214,0.92 [0.74-1.15],0.4649532545729228
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22770,76,1.12 [0.79-1.58],0.5415390996020242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21135,538,0.98 [0.86-1.13],0.8017754564769929
